Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Three Made in India drugs recalled in US- FDA

      Three Made in India drugs recalled in US- FDA

      supriya kashyap kashyap8 Dec 2016 12:20 PM IST
      New Delhi : Three different drugs made in India, including by Cadila Pharma and Alkem Laboratories, are being recalled in the US for not meeting the...
      Pfizer fined record 106 million dollars for unfair prices of epilepsy drug

      Pfizer fined record 106 million dollars for unfair prices of epilepsy drug

      supriya kashyap kashyap8 Dec 2016 12:05 PM IST
      Britain's competition regulator imposed a record 84.2 million pound ($106 million) fine on the pharmaceutical manufacturer Pfizer, and a 5.2 million...
      Pfizers Herceptin biosimilar succeeds in key breast cancer study

      Pfizer's Herceptin biosimilar succeeds in key breast cancer study

      supriya kashyap kashyap8 Dec 2016 9:18 AM IST
      Pfizer Inc said its experimental biosimilar of Roche Holding AG's blockbuster breast cancer treatment Herceptin was found comparable with the branded...
      Strides Shasun R&D unit gets USFDA inspection closure report

      Strides Shasun R&D unit gets USFDA inspection closure report

      supriya kashyap kashyap8 Dec 2016 9:16 AM IST
      New Delhi : Drug firm Strides Shasun has received Establishment Inspection Report (EIR) from the US health regulator on closure of inspection of its...
      Lupin gets USFDA nod for Diclofenac capsules generic version

      Lupin gets USFDA nod for Diclofenac capsules generic version

      supriya kashyap kashyap8 Dec 2016 9:15 AM IST
      Pharma major Lupin said it has received tentative approval for its generic version of Diclofenac capsules, used in pain management of osteoarthritis,...
      AstraZeneca pill slashes lung cancer progression in study

      AstraZeneca pill slashes lung cancer progression in study

      supriya kashyap kashyap8 Dec 2016 9:14 AM IST
      AstraZeneca's pill Tagrisso cut the risk of lung cancer progressing by 70 percent compared to standard chemotherapy in a major clinical trial, lifting...
      79 demand notices issued to drug cos for overcharging: Govt

      79 demand notices issued to drug cos for overcharging: Govt

      supriya kashyap kashyap8 Dec 2016 9:10 AM IST
      New Delhi : National drug price regulator NPPA has issued 79 demand notices to pharmaceutical companies for overcharging for non-scheduled...
      Delhi HC pulls up Government on fixing MRP of coronary stents

      Delhi HC pulls up Government on fixing MRP of coronary stents

      supriya kashyap kashyap7 Dec 2016 3:09 PM IST
      New Delhi : The Delhi High Court asked the Centre as to why the maximum retail price (MRP) of coronary stents, used to treat narrowed or weakened...
      Anti-aging pill maker Elysium Health raises $20 million

      Anti-aging pill maker Elysium Health raises $20 million

      supriya kashyap kashyap7 Dec 2016 12:22 PM IST
      Dietary supplement maker Elysium Health Inc said it raised $20 million in funding from a group of investors led by venture capital firm General...
      Bhattacharjee named as generics group head by Teva

      Bhattacharjee named as generics group head by Teva

      supriya kashyap kashyap7 Dec 2016 12:19 PM IST
      Teva Pharmaceutical Industries, the world's biggest generic drugmaker, has appointed Dipankar Bhattacharjee as chief executive for its global generic...
      Alembic Pharma gets USFDA nod for anti-migraine drug

      Alembic Pharma gets USFDA nod for anti-migraine drug

      supriya kashyap kashyap7 Dec 2016 12:18 PM IST
      New Delhi : Alembic Pharmaceuticals has received approval from the US health regulator for Zolmitriptan Orally Disintegrating tablets, used for the...
      Pfizer blood cancer drug tops standard therapy for untreated patients

      Pfizer blood cancer drug tops standard therapy for untreated patients

      supriya kashyap kashyap7 Dec 2016 12:17 PM IST
      Pfizer Inc said its cancer drug, Bosulif, was found superior to Novartis AG's Gleevec in a late-stage study on untreated patients with a form of blood...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok